Fujifilm deepens its CMO heft with Kalon buyout

Fujifilm has completed its acquisition of Kalon Biotherapeutics, a contract manufacturer with a focus on vaccines. The Japanese company acquired a stake in Kalon back in October and is now closing the gap with plans to integrate the company into its Diosynth unit. Story